Champions Oncology (CSBR) Share-based Compensation (2010 - 2026)
Champions Oncology (CSBR) posted Share-based Compensation of $357000.0 for Q2 2026, down 15.6% on a QoQ basis from $423000.0 in Q1 2026, and up 172.52% year-over-year from $131000.0 in Q2 2025.
Powered by 
Analysis
Champions Oncology (CSBR) Share-based Compensation (2010 - 2026) Analysis & Trends
Champions Oncology has reported Share-based Compensation for 17 years, with the latest figure at $357000.0 in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 172.52% year-over-year to $357000.0 in Q2 2026; TTM through Apr 2026 was $1.2 million, a 89.14% increase from a year earlier, with the FY2026 full-year figure at $1.2 million, up 89.14% from the prior year.
- Share-based Compensation was $357000.0 for Q2 2026 at Champions Oncology, down from $423000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $423000.0 in Q3 2023, with the low at $9000.0 in Q4 2024.
- Average Share-based Compensation over 5 years is $242833.3, with a median of $252500.0 recorded in 2025.
- The sharpest annual moves came in 2022 and 2025: Share-based Compensation sank 91.64% in 2022, then surged 2666.67% in 2025.
- Over 5 years, Share-based Compensation stood at $119000.0 in 2022, then tumbled by 55.46% to $53000.0 in 2023, then plunged by 83.02% to $9000.0 in 2024, then soared by 2666.67% to $249000.0 in 2025, then jumped by 43.37% to $357000.0 in 2026.
- The last three Share-based Compensation figures came in at $357000.0 (Q2 2026), $423000.0 (Q1 2026), and $249000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 95.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 4.35 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 19.78 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 18.46 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 12.60 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 7.60 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 357,000.00 |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 590,899.88 |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 91,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 357,000.00 |
| Jan 31, 2026 | 423,000.00 |
| Oct 31, 2025 | 249,000.00 |
| Jul 31, 2025 | 208,000.00 |
| Apr 30, 2025 | 131,000.00 |
| Jan 31, 2025 | 256,000.00 |
| Oct 31, 2024 | 9,000.00 |
| Jul 31, 2024 | 258,000.00 |
| Apr 30, 2024 | 263,000.00 |
| Jan 31, 2024 | 379,000.00 |
| Oct 31, 2023 | 53,000.00 |
| Jul 31, 2023 | 423,000.00 |
| Apr 30, 2023 | 208,000.00 |
| Jan 31, 2023 | 331,000.00 |
| Oct 31, 2022 | 119,000.00 |
| Jul 31, 2022 | 206,000.00 |
| Apr 30, 2022 | 188,000.00 |
| Jan 31, 2022 | 310,000.00 |
| Oct 31, 2021 | 134,000.00 |
| Jul 31, 2021 | 280,000.00 |